Novo Nordisk A/S

Novo Nordisk A/S

Verified
Global healthcare company with 95 years of innovation and leadership in diabetes care

Launch date
Employees
Market cap
$224.0b
Net debt
$740m
Firm valuation
$223.3b (Public information from Sep 2022)
Bagsværd Capital Region of Denmark (HQ)
Corporate Venture Fund: Novo Ventures, Novo Holdings
Name
Market
Type
Location
Last Round
Status